UVE shorts retreat as retail attention spikes post-earnings
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Universal Insurance Holdings has seen a sharp reversal in short positioning in the six days since Q3 results. The borrow market has moved decisively in the same direction, and retail attention has jumped to its highest relative level in months.
The post-earnings short unwind
Short interest fell 21% in a single week to 863,638 shares, or 3.1% of free float, the lowest level since early October. That reverses almost the entire build that accumulated around October 8 to 9, when shorts nearly doubled from roughly 632,000 to 1.1 million shares. The unwind gathered pace immediately after the October 22 to 23 earnings period, when the stock moved 2.3% higher on the day.
The ORTEX short score has dropped in step: from 41.7 on October 16 to 37.4 today. That decline reflects a broad easing of short-side pressure across the metrics ORTEX tracks.
Borrow costs collapse, availability surges
The lending market has swung from moderately priced to essentially free. Cost to borrow fell to 0.79%, down 86% over the week and down 99.6% over the past month, when it regularly traded between 1.5% and 2.8%. Availability now sits at 9,999%, meaning there are roughly 100 shares available to lend for every one currently borrowed. A week ago availability was already loose; today the borrow pool is almost entirely unused. There is no mechanical constraint on new short positions, yet short sellers are not adding.
Retail attention surges above trend
Wikipedia views and ORTEX stock page traffic combined to produce a retail attention reading 3.27 standard deviations above UVE's own 90-day average as of October 27. That is attention, not a revenue indicator, but the timing is consistent with post-earnings curiosity from individual investors examining a stock that has climbed roughly 9% over the past month.
Analyst and options context
Piper Sandler's Paul Newsome raised his price target to $51 from $45 on October 26, maintaining a Neutral rating. The stock closed at $45.98 on October 28, leaving implied upside to the new target of roughly 11%. The put/call ratio stands at 0.22, close to its recent lows and well below the 20-day average of 0.55, consistent with the bullish tilt noted in the pre-earnings preview published on October 23.
What to watch: whether short interest continues its descent below 3% of float, or whether sellers return as the stock approaches the $51 analyst target.
Data summary
- SI % of FF: 3.1% (down 21% over one week)
- Cost to borrow: 0.79% (down 86% over one week)
- Availability: 9,999%
- ORTEX short score: 37.4 (from 41.7 on October 16)
- Retail attention z-score: 3.27 vs own 90-day average (as of October 27)
- PCR: 0.22 vs 20-day average of 0.55
- Piper Sandler price target: $51 (raised from $45, October 26)
Stocks in this article
See the live data behind this article on ORTEX.
Open UVE on ORTEX →How this article was generated
- Generated
- 29 Oct 2026, 20:29
- Data as of
- 29 Oct 2026, 20:22
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.